Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.

ResearchSpace Repository

Files in this item

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Advanced Search

Browse

Statistics